Incontinence and other urinary problems after prostate cancer treatment can be eased with Kegel exercises, bladder training, ...
Manufacturing optimization is projected to expand batch output by ~50%, improving supply reliability and supporting higher-throughput PSMA PET imaging services. Increased radioactivity extends shelf ...
The charity's campaign is calling for sanitary bins in men's public toilets to help with male incontinence ...
FDA approved Pylarify TruVu, a higher-radioactivity-concentration formulation of piflufolastat F 18 designed to increase batch size and distribution efficiency while maintaining the established ...
Clinical node involvement on preoperative PSMA-PET predicts radiographic recurrence for pN1 prostate cancer patients following RP/PLND.
The Inflation Reduction Act (IRA) represents a transformative shift in US health care policy by enabling Medicare to negotiate drug prices for high-expenditure medicatio ...
About 60% of low‑risk prostate cancer patients are opting for active surveillance — and long‑term survival remains high.
Blood tests are the most common way for health professionals to detect and diagnose a range of medical conditions. But can it ...
PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.
If you’re feeling worn out or have suddenly lost some weight, your doctor might send you for a blood test. Blood tests are a common way health-care professionals detect, diagnose, and monitor a range ...
New formulation of its widely-used U.S. market-leading PSMA PET imaging agentcombines thediagnostic performance of PYLARIFY® (piflufolastat F 18) ...
Oncology Media Relations oncology_media_relations@its.jnj.com Investor contact: Jessica Margevich investor-relations@its.jnj.com ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results